No phaseRecruiting
Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD (DCBMultivessel)
Clinical Impact of Drug-Coated-Balloon-based Versus Drug-Eluting-Stent-based Intervention in Patients With Multivessel Coronary Artery Disease : A Prospective, Multicenter, Active-controlled, Randomized, Single-blind, Investigator-initiated Clinical Trial
- Sponsor
- Genoss Co., Ltd. (Industry)
- Enrolment
- 892 planned
- Conditions
- Multi Vessel Coronary Artery Disease; Percutaneous Coronary Intervention
- Interventions
- GENOSS® DCB (Paclitaxel-coated PTCA balloon catheter); Contemporary Drug-Eluting Stents (DES)
- Ages
- adults, older adults
- Registry
- NCT07539324
Full record on ClinicalTrials.gov
From the registry
This study aimes to compare the clinical outcomes of drug-coated balloon-based percutaneous coronary intervention (DCB-based PCI) and drug-eluting stent-based percutaneous coronary intervention (DES-based PCI) in patients with multivessel coronary artery lesions measuring 2.25 mm to 4.0 mm in diameter through a prospective, multicenter, active-controlled, randomized, investigator-initiated clinical trial.
Primary outcomes
- Net Clinical outcome (NCO)
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered